BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24882402)

  • 1. 3-Monoglucuronyl glycyrrhretinic acid is a possible marker compound related to licorice-induced pseudoaldosteronism.
    Makino T
    Biol Pharm Bull; 2014; 37(6):898-902. PubMed ID: 24882402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Monoglucuronyl-glycyrrhretinic acid is a substrate of organic anion transporters expressed in tubular epithelial cells and plays important roles in licorice-induced pseudoaldosteronism by inhibiting 11β-hydroxysteroid dehydrogenase 2.
    Makino T; Okajima K; Uebayashi R; Ohtake N; Inoue K; Mizukami H
    J Pharmacol Exp Ther; 2012 Aug; 342(2):297-304. PubMed ID: 22543032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration for the real causative agents of licorice-induced pseudoaldosteronism.
    Makino T
    J Nat Med; 2021 Mar; 75(2):275-283. PubMed ID: 33481180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18β-glycyrrhetyl-3-O-sulfate would be a causative agent of licorice-induced pseudoaldosteronism.
    Ishiuchi K; Morinaga O; Ohkita T; Tian C; Hirasawa A; Mitamura M; Maki Y; Kondo T; Yasujima T; Yuasa H; Minamizawa K; Namiki T; Makino T
    Sci Rep; 2019 Feb; 9(1):1587. PubMed ID: 30733510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Monoglucuronyl-glycyrrhetinic acid is a major metabolite that causes licorice-induced pseudoaldosteronism.
    Kato H; Kanaoka M; Yano S; Kobayashi M
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1929-33. PubMed ID: 7775643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of a novel glycyrrhizin metabolite as a causal candidate compound for pseudoaldosteronism.
    Morinaga O; Ishiuchi K; Ohkita T; Tian C; Hirasawa A; Mitamura M; Maki Y; Yasujima T; Yuasa H; Makino T
    Sci Rep; 2018 Oct; 8(1):15568. PubMed ID: 30348944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of a hepatic transporter multidrug resistance-associated protein 2 is involved in alteration of pharmacokinetics of glycyrrhizin and its metabolites in a rat model of chronic liver injury.
    Makino T; Ohtake N; Watanabe A; Tsuchiya N; Imamura S; Iizuka S; Inoue M; Mizukami H
    Drug Metab Dispos; 2008 Jul; 36(7):1438-43. PubMed ID: 18362159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of glycyrrhizin metabolites in humans and of a potential biomarker of liquorice-induced pseudoaldosteronism: a multi-centre cross-sectional study.
    Takahashi K; Yoshino T; Maki Y; Ishiuchi K; Namiki T; Ogawa-Ochiai K; Minamizawa K; Makino T; Nakamura T; Mimura M; Watanabe K
    Arch Toxicol; 2019 Nov; 93(11):3111-3119. PubMed ID: 31605160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible involvement of 3-monoglucuronyl-glycyrrhetinic acid, a metabolite of glycyrrhizin (GL), in GL-induced pseudoaldosteronism.
    Ohtake N; Kido A; Kubota K; Tsuchiya N; Morita T; Kase Y; Takeda S
    Life Sci; 2007 Apr; 80(17):1545-52. PubMed ID: 17331546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Risk Factors of Licorice-Induced Pseudoaldosteronism Based on Glycyrrhizin-Metabolite Concentrations: A Narrative Review.
    Yoshino T; Shimada S; Homma M; Makino T; Mimura M; Watanabe K
    Front Nutr; 2021; 8():719197. PubMed ID: 34604277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule.
    Lan XF; Olaleye OE; Lu JL; Yang W; Du FF; Yang JL; Cheng C; Shi YH; Wang FQ; Zeng XS; Tian NN; Liao PW; Yu X; Xu F; Li YF; Wang HT; Zhang NX; Jia WW; Li C
    Acta Pharmacol Sin; 2021 Dec; 42(12):2155-2172. PubMed ID: 33931765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse effects of licorice consumed as food: An update].
    Caré W; Grenet G; Schmitt C; Michel S; Langrand J; Le Roux G; Vodovar D
    Rev Med Interne; 2023 Sep; 44(9):487-494. PubMed ID: 37005098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for pseudoaldosteronism with rhabdomyolysis caused by consumption of drugs containing licorice and differences between incidence of these conditions in Japan and other countries: case report and literature review.
    Yoshino T; Yanagawa T; Watanabe K
    J Altern Complement Med; 2014 Jun; 20(6):516-20. PubMed ID: 24620820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice.
    Shibata S
    Yakugaku Zasshi; 2000 Oct; 120(10):849-62. PubMed ID: 11082698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the exposure of glycyrrhizin and its metabolites and the pseudoaldosteronism after intravenous administration of alpha- and beta-glycyrrhizin in rat.
    Xu R; Xiao Q; Cao Y; Yang J
    Drug Res (Stuttg); 2013 Dec; 63(12):620-4. PubMed ID: 23864391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Study of Factors Associated with the Development of Pseudoaldosteronism in Outpatients.
    Mantani N; Oka H; Watanabe T
    J Altern Complement Med; 2020 Apr; 26(4):329-334. PubMed ID: 31977240
    [No Abstract]   [Full Text] [Related]  

  • 17. [Scientific Evaluation of Crude Drugs and Kampo Medicines Using the Eastern Blotting Method and Its Application to Biological Metabolic Studies].
    Morinaga O
    Yakugaku Zasshi; 2018; 138(6):743-750. PubMed ID: 29863039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an Alternative Glycyrrhizin Metabolite Causing Liquorice-Induced Pseudohyperaldosteronism and the Development of ELISA System to Detect the Predictive Biomarker.
    Ishiuchi K; Morinaga O; Yoshino T; Mitamura M; Hirasawa A; Maki Y; Tashita Y; Kondo T; Ogawa K; Lian F; Ogawa-Ochiai K; Minamizawa K; Namiki T; Mimura M; Watanabe K; Makino T
    Front Pharmacol; 2021; 12():688508. PubMed ID: 34079468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactive Candy: Effects of Licorice on the Cardiovascular System.
    Deutch MR; Grimm D; Wehland M; Infanger M; Krüger M
    Foods; 2019 Oct; 8(10):. PubMed ID: 31615045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2.
    Kratschmar DV; Vuorinen A; Da Cunha T; Wolber G; Classen-Houben D; Doblhoff O; Schuster D; Odermatt A
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):129-42. PubMed ID: 21236343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.